1/41
Comprehensive vocabulary flashcards covering epidemiology concepts, innate and adaptive immunity, hypersensitivities, immunodeficiencies, HIV/AIDS pathology, and viral disease mechanisms.
Epidemiology
The study of disease frequency, spread, and control in a population.
Etiology
The study of the cause of a disease.
Incidence
The number of new cases of a disease arising in a given population.
Prevalence
The percentage of a population that has a disease, accounting for both new and existing cases.
Endemic
Referring to a disease that is continually present in a population.
Epidemic
A disease outbreak characterized by a higher than normal incidence in a population.
Common Source Epidemic
An epidemic resulting from contact with contaminated substances, characterized by a rapid rise and rapid decline in cases.
Propagated Epidemic
An epidemic driven by horizontal (person-to-person) transmission, characterized by a gradual rise and gradual decline in cases.
Pathogenicity
The capacity of an organism to produce disease, ranging on a spectrum from low to high.
Virulence
The intensity and severity of the disease caused by a given pathogen.
Attenuation
The weakening of a pathogen's virulence, occurring naturally or accomplished through genetic manipulation.
Transposal of Virulence
The repeated passage of a pathogen into a novel host species until it is no longer virulent to its original host.
Fomites
Nonliving objects that harbor an infectious agent and facilitate indirect contact transmission.
Herd Immunity
The resistance of an entire group to infection when a critical threshold of the population is immunized, such as 70% for polio or 90% for influenza.
Nosocomial Infections
Infections acquired by patients during a stay in a medical facility.
Zoonoses
Diseases that are naturally transmissible to humans from other vertebrate animals (such as COVID, hantavirus, or anthrax).
Microbial Antagonism
The ability of the resident normal microflora to suppress pathogens by competing for attachment sites and nutrients.
Antigen
A foreign substance (usually a protein, sometimes a polysaccharide) recognized by the body that triggers an immune response.
Epitope
The specific area or structural motif on the surface of an antigen to which an antibody binds.
Immunoglobulin G (IgG)
The major antibody class involved in the secondary immune response, produced rapidly by memory B cells without requiring initial helper T-cell activation.
Immunoglobulin M (IgM)
The first antibody class generated during the primary immune response when a naive B cell first interacts with an antigen in coordination with a helper T cell.
Phagocytosis
A four-step cellular defense mechanism executed by neutrophils and macrophages comprising chemotaxis, adherence and ingestion, digestion within lysosomes, and egestion of debris.
Leukocidins
Bacterial toxins secreted to destroy white blood cells (leukocytes), leading to pus formation.
Cardinal Signs of Inflammation
The four hallmark manifestations of local tissue inflammation: calor (heat), rubor (redness), tumor (swelling), and dolor (pain).
Pyrogens
Circulating fever-inducing substances that reset the hypothalamus body thermostat to temperatures exceeding 100.5∘F.
Clonal Selection Theory
The principle that each individual B and T lymphocyte is pre-programmed to recognize only one specific antigen, conferring specificity and memory to adaptive immunity.
Antigen Presenting Cell (APC)
An immune cell (such as a macrophage) that ingests and lyses pathogens, processing their antigens and presenting them on its surface bound to MHC proteins to activate helper T cells.

Retrovirus Replication Cycle
A viral life cycle starting with entrance and uncoating of ssRNA, followed by reverse transcription to dsDNA, nuclear entry and host genome integration as a provirus, transcription, encapsidation into nucleocapsids, and budding from the cytoplasmic membrane.

Overview of the Immune System
An integrated defense network where innate macrophage APCs present antigens to helper T (TH) cells, which subsequently stimulate cytotoxic T (TC) cells in cell-mediated immunity and B cells to secrete antibodies in humoral immunity.
Cell-Mediated Immunity
The branch of adaptive immunity directed by T cells that destroys virus-infected host cells and foreign grafted tissues without generating antibodies.
Humoral Immunity
The antibody-mediated component of adaptive immunity wherein B cells differentiate into antibody-secreting plasma cells that clear pathogens in the blood and bodily fluids.
Toxoid
An inactivated or chemically altered microbial toxin that stimulates protective antibody production without causing disease, frequently requiring booster doses.
Type I Hypersensitivity
An immediate, anaphylactic allergic response wherein initial exposure stimulates IgE binding to mast cells and basophils, triggering degranulation and histamine release upon subsequent allergen exposure.
Type II Hypersensitivity
A cytotoxic hypersensitivity reaction caused by antibody binding to cell-surface antigens that incites tissue destruction, as seen in ABO blood transfusion mismatches and mother-infant Rh incompatibility.
Type III Hypersensitivity
An immune complex-mediated hypersensitivity characterized by the deposition of excess antigen-antibody aggregates in tissues, vessels, and joints, triggering inflammatory conditions like serum sickness and the Arthus reaction.
Type IV Hypersensitivity
A delayed hypersensitivity reaction taking 12 or more hours to develop that is mediated by T lymphocytes rather than circulating antibodies (such as contact dermatitis from poison ivy urushiol oil).
Severe Combined Immunodeficiency (SCID)
A primary genetic immunodeficiency disease marked by an inability to produce functional B cells or T cells, treatable via bone marrow transplantation.
Human Immunodeficiency Virus (HIV)
An enveloped single-stranded RNA retrovirus whose gp120 surface glycoprotein binds CD4 receptors and CCR5 co-receptors, utilizing reverse transcriptase to replicate.
Acquired Immunodeficiency Syndrome (AIDS)
The clinical condition diagnosed in an HIV-positive individual when their helper T-cell count drops below 200/mm3 or when designated opportunistic infections (e.g., Kaposi's sarcoma, pneumocystic pneumonia) develop.
Highly Active Antiretroviral Therapy (HAART)
A multi-drug therapeutic cocktail designed to decrease HIV viral load and delay drug resistance, usually combining two NRTIs with either a protease inhibitor or an NNRTI.
Antigenic Drift
Minor genetic alterations occurring via point mutations in influenza hemagglutinin (H) and neuraminidase (N) genes, leading to localized seasonal epidemics.
Antigenic Shift
Major, abrupt reassortments among the eight segmented RNA strands of influenza viruses that introduce novel H and N surface proteins, capable of triggering global pandemics.